Texas Technology Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Texas Technology Digest.

Press releases published on June 8, 2026

Jun. 8, 2026

Kymera Therapeutics Presents New Preclinical Lupus Data for KT-579, First-in-Class, Oral IRF5 Degrader, at EULAR and FOCIS Congresses

Indeterminate GlobeNewswire

Jun. 8, 2026

Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for TONMYA®, Expanding Total Commercial Coverage to ~52 Million U.S. Lives

Indeterminate GlobeNewswire

Jun. 8, 2026

Introducing HRCI ONE: New All-Access Annual Subscription for Every Stage of the HR Career Journey

Indeterminate GlobeNewswire

Jun. 8, 2026

Marvel Biosciences Receives Notice of Allowance for Australian Patent Application Covering Composition of Matter for its Lead Therapeutic Candidate MB-204

Indeterminate GlobeNewswire

Jun. 8, 2026

Sequel Presents Pivotal Trial of the twiist™ Automated Insulin Delivery System in Adults with Insulin-Treated Type 2 Diabetes at the ADA 86th Scientific Sessions

Indeterminate GlobeNewswire

Jun. 8, 2026

Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes (T1D) at UChicago Medicine

Indeterminate GlobeNewswire

Jun. 8, 2026

Ambow Education to Host HybriU™ Open House at NewSchool of Architecture and Design During AIA Conference on Architecture & Design 2026 in San Diego

Indeterminate GlobeNewswire

Jun. 8, 2026

Upstream Bio to Showcase Additional Efficacy Data from the Phase 2 VIBRANT Trial of Verekitug in CRSwNP in Oral Session at EAACI 2026

Indeterminate GlobeNewswire

Jun. 8, 2026

Tango Therapeutics Announces Combination of Vopimetostat and Daraxonrasib Demonstrated 92% Objective Response Rate in Pancreatic Cancer

Indeterminate GlobeNewswire

Jun. 8, 2026

SPARC AI Inc. Announces Closing of Final Tranche of Brokered LIFE Financing for $1.12 Million

Indeterminate GlobeNewswire

Jun. 8, 2026

Aeries Technology Reports Fiscal Year 2026 Results

Indeterminate GlobeNewswire

Jun. 8, 2026

Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today

Indeterminate GlobeNewswire

Jun. 8, 2026

Engitix Announces Strategic Collaboration with GSK to Advance First-in-Class Targets for Liver Fibrosis Regression

Indeterminate GlobeNewswire

Jun. 8, 2026

HP Recognized as a Leader in the 2026 Gartner® Magic Quadrant™ for Digital Employee Experience (DEX) Management Tools

Indeterminate GlobeNewswire

Jun. 8, 2026

Shattuck Labs Announces Phase 1 Results for SL-325

Indeterminate GlobeNewswire

Jun. 8, 2026

Lyell Immunopharma Provides Update on Safety Profile of LYL273 in Relapsed or Refractory Metastatic Colorectal Cancer and Amends Phase 1 Trial to Phase 1/2 Expansion 

Indeterminate GlobeNewswire

Jun. 8, 2026

ERShares Announces XOVR Shareholder Protection Plan Ahead of the SpaceX IPO

Indeterminate GlobeNewswire

Jun. 8, 2026

Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio®

Indeterminate GlobeNewswire

Jun. 8, 2026

Yeahka (9923.HK) Q1 Overseas Payment GPV Surges Nearly Fourfold to RMB2,439 Million

Indeterminate GlobeNewswire

Jun. 8, 2026

移卡召開2026股東周年大會，公布Q1海外支付GPV增至同期4倍至24.39億元

Indeterminate GlobeNewswire